{"id":417,"date":"2021-12-19T11:01:07","date_gmt":"2021-12-19T10:01:07","guid":{"rendered":"https:\/\/medtechkey.com\/index.php\/embed-link\/"},"modified":"2021-12-30T15:54:23","modified_gmt":"2021-12-30T14:54:23","slug":"news","status":"publish","type":"page","link":"https:\/\/medtechkey.com\/index.php\/news\/","title":{"rendered":"News"},"content":{"rendered":"\n<div class=\"wp-block-group alignfull has-neve-text-color-color has-nv-c-2-background-color has-text-color has-background\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h1 class=\"alignwide has-text-align-center wp-block-heading\">Latest Medtech News<\/h1>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<div class=\"wp-block-group alignfull has-nv-light-bg-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"has-text-align-center wp-block-heading\">Top Stories<\/h2>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><ul class=\"simple-links-list\" ><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-855\"><a href=\"https:\/\/www.linkedin.com\/pulse\/medtech-ma-roars-back-2025-rebound-sets-stage-2026-portfolio-lafon-r7tue\/?trackingId=NFsCl0nSSIWH3jC23DPr9w%3D%3D\" title=\"Medtech M&amp;A roared back in 2025, with deal value, spin\u2011offs, and portfolio reshaping all accelerating\u2014and 2026 already continuing the trend.\r\n\r\nAfter a muted 2023\u20132024, medtech dealmaking decisively rebounded in 2025, both in scale and in strategic clarity.\r\n\r\nOne of the most important shifts in 2025 was the normalization of spin\u2011offs and divestitures as a core lever of portfolio strategy, not a one\u2011off response to activist pressure.\r\n\r\nLooking into 2026, Bain argues that enduring softer valuations will heighten competition for high\u2011quality assets, forcing acquirers to be explicit about where they can \u201coutperform the next\u2011best owner.\u201d That means articulating a clear value\u2011creation thesis\u2014scale advantages, superior go\u2011to\u2011market capabilities, or unique strategic fit\u2014before deals are signed, not retrofitted afterwards.\" target=\"_blank\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"169\" src=\"https:\/\/medtechkey.com\/wp-content\/uploads\/2026\/01\/1769623395299-300x169.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/medtechkey.com\/wp-content\/uploads\/2026\/01\/1769623395299-300x169.png 300w, https:\/\/medtechkey.com\/wp-content\/uploads\/2026\/01\/1769623395299-1024x576.png 1024w, https:\/\/medtechkey.com\/wp-content\/uploads\/2026\/01\/1769623395299-768x432.png 768w, https:\/\/medtechkey.com\/wp-content\/uploads\/2026\/01\/1769623395299.png 1280w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><br>Medtech M&A Roars Back: 2025 Rebound Sets Stage for 2026 Portfolio Wars<\/a> <span class=\"link-description\"><p>Medtech M&amp;A roared back in 2025, with deal value, spin\u2011offs, and portfolio reshaping all accelerating\u2014and 2026 already continuing the trend.<\/p>\n<p>After a muted 2023\u20132024, medtech dealmaking decisively rebounded in 2025, both in scale and in strategic clarity.<\/p>\n<p>One of the most important shifts in 2025 was the normalization of spin\u2011offs and divestitures as a core lever of portfolio strategy, not a one\u2011off response to activist pressure.<\/p>\n<p>Looking into 2026, Bain argues that enduring softer valuations will heighten competition for high\u2011quality assets, forcing acquirers to be explicit about where they can \u201coutperform the next\u2011best owner.\u201d That means articulating a clear value\u2011creation thesis\u2014scale advantages, superior go\u2011to\u2011market capabilities, or unique strategic fit\u2014before deals are signed, not retrofitted afterwards.<\/p>\n<\/span><\/li><\/ul><!-- End .simple-links-list -->\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><ul class=\"simple-links-list\" ><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-863\"><a href=\"https:\/\/www.medtechdive.com\/news\/medtech-ma-starts-off-strong-in-2026\/813228\/\" title=\"After medical device M&amp;A picked up last year, 2026 is off to a busy start. Boston Scientific\u2019s planned $14.5 billion acquisition of Penumbra, a company that makes thrombectomy and embolization devices, was the largest purchase so far this year.\r\n\r\nIn another multibillion-dollar deal, Danaher announced plans this month to buy patient monitoring firm Masimo.\r\n\r\nSeveral medtech firms have also announced major divestitures in the past year. Some notable ones to watch include BD\u2019s planned $17.5 billion sale of its biosciences and diagnostics businesses, Medtronic\u2019s planned spinoff of its diabetes business into a publicly traded company, and Johnson &amp;Johnson\u2019s planned divestiture of its orthopedics segment.\" target=\"_blank\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"169\" src=\"https:\/\/medtechkey.com\/wp-content\/uploads\/2025\/03\/Untitled_design_-_2025-01-24T082631.444-300x169.webp\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/medtechkey.com\/wp-content\/uploads\/2025\/03\/Untitled_design_-_2025-01-24T082631.444-300x169.webp 300w, https:\/\/medtechkey.com\/wp-content\/uploads\/2025\/03\/Untitled_design_-_2025-01-24T082631.444-1024x576.webp 1024w, https:\/\/medtechkey.com\/wp-content\/uploads\/2025\/03\/Untitled_design_-_2025-01-24T082631.444-768x432.webp 768w, https:\/\/medtechkey.com\/wp-content\/uploads\/2025\/03\/Untitled_design_-_2025-01-24T082631.444.webp 1280w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><br>Medtech M&A starts off strong in 2026<\/a> <span class=\"link-description\"><p>After medical device M&amp;A picked up last year, 2026 is off to a busy start. Boston Scientific\u2019s planned $14.5 billion acquisition of Penumbra, a company that makes thrombectomy and embolization devices, was the largest purchase so far this year.<\/p>\n<p>In another multibillion-dollar deal, Danaher announced plans this month to buy patient monitoring firm Masimo.<\/p>\n<p>Several medtech firms have also announced major divestitures in the past year. Some notable ones to watch include BD\u2019s <a href=\"https:\/\/www.medtechdive.com\/news\/bd-split-life-science-business-medtech-investment\/739520\/\">planned $17.5 billion sale<\/a> of its biosciences and diagnostics businesses, Medtronic\u2019s <a href=\"https:\/\/www.medtechdive.com\/news\/medtronics-minimed-prices-ipo-at-up-to-784m\/812972\/\">planned spinoff<\/a> of its diabetes business into a publicly traded company, and <a href=\"https:\/\/www.medtechdive.com\/news\/jnj-spin-out-orthopedics\/802696\/\">Johnson &amp;Johnson\u2019s planned divestiture<\/a> of its orthopedics segment.<\/p>\n<\/span><\/li><\/ul><!-- End .simple-links-list -->\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<div class=\"wp-block-group alignfull has-nv-light-bg-background-color has-background\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"has-text-align-center wp-block-heading\">Latest News<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><ul class=\"simple-links-list\" ><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-863\"><a href=\"https:\/\/www.medtechdive.com\/news\/medtech-ma-starts-off-strong-in-2026\/813228\/\" title=\"After medical device M&amp;A picked up last year, 2026 is off to a busy start. Boston Scientific\u2019s planned $14.5 billion acquisition of Penumbra, a company that makes thrombectomy and embolization devices, was the largest purchase so far this year.\r\n\r\nIn another multibillion-dollar deal, Danaher announced plans this month to buy patient monitoring firm Masimo.\r\n\r\nSeveral medtech firms have also announced major divestitures in the past year. Some notable ones to watch include BD\u2019s planned $17.5 billion sale of its biosciences and diagnostics businesses, Medtronic\u2019s planned spinoff of its diabetes business into a publicly traded company, and Johnson &amp;Johnson\u2019s planned divestiture of its orthopedics segment.\" target=\"_blank\" >Medtech M&A starts off strong in 2026<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-861\"><a href=\"https:\/\/www.massdevice.com\/johnson-johnson-medtech-eyes-20b-ortho-sale\/\" title=\"\" target=\"_blank\" >Johnson & Johnson MedTech reportedly eyes $20B deal to sell DePuy Synthes ortho unit<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-859\"><a href=\"https:\/\/www.proactiveinvestors.com\/companies\/news\/1087489\/danaher-to-acquire-masimo-in-9-9b-all-cash-deal-1087489.html\" title=\"\" target=\"_blank\" >Danaher to acquire Masimo in $9.9B all-cash deal<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-855\"><a href=\"https:\/\/www.linkedin.com\/pulse\/medtech-ma-roars-back-2025-rebound-sets-stage-2026-portfolio-lafon-r7tue\/?trackingId=NFsCl0nSSIWH3jC23DPr9w%3D%3D\" title=\"Medtech M&amp;A roared back in 2025, with deal value, spin\u2011offs, and portfolio reshaping all accelerating\u2014and 2026 already continuing the trend.\r\n\r\nAfter a muted 2023\u20132024, medtech dealmaking decisively rebounded in 2025, both in scale and in strategic clarity.\r\n\r\nOne of the most important shifts in 2025 was the normalization of spin\u2011offs and divestitures as a core lever of portfolio strategy, not a one\u2011off response to activist pressure.\r\n\r\nLooking into 2026, Bain argues that enduring softer valuations will heighten competition for high\u2011quality assets, forcing acquirers to be explicit about where they can \u201coutperform the next\u2011best owner.\u201d That means articulating a clear value\u2011creation thesis\u2014scale advantages, superior go\u2011to\u2011market capabilities, or unique strategic fit\u2014before deals are signed, not retrofitted afterwards.\" target=\"_blank\" >Medtech M&A Roars Back: 2025 Rebound Sets Stage for 2026 Portfolio Wars<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-853\"><a href=\"https:\/\/www.fiercebiotech.com\/medtech\/medtech-ma-rebounded-2025-softer-valuations-drive-competition-report\" title=\"\" target=\"_blank\" >Medtech M&A 'rebounded' in 2025 as softer valuations drove deal competition<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-850\"><a href=\"https:\/\/www.massdevice.com\/medtech-biggest-deals-of-2025\/\" title=\"In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&amp;A) arena.\r\n\r\nPrivate equity played its part, while some of medtech\u2019s biggest names made further moves to try and enhance their portfolios. Last year, along with the biggest deals of 2024, analysts suggested that, in 2025, there could be even more significant M&amp;A deals to come. That appears to have come true.\r\n\r\nOver the course of the year, several deals eclipsed the billion-dollar mark. Here they are...\" target=\"_blank\" >Medtech M&A: The biggest deals of 2025<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-848\"><a href=\"https:\/\/www.bain.com\/insights\/medtech-m-and-a-report-2026\/\" title=\"\" target=\"_blank\" >M&A in Medtech: The Boom in Portfolio Reshaping<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-846\"><a href=\"https:\/\/www.massdevice.com\/boston-scientific-to-acquire-penumbra-for-14-5b\/\" title=\"\" target=\"_blank\" >Boston Scientific to acquire Penumbra for $14.5B<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-843\"><a href=\"https:\/\/www.medtechdive.com\/news\/hologic-acquired-18b-blackstone-tpg\/803361\/\" title=\"\" target=\"_blank\" >Hologic to go private for up to $18.3B<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-841\"><a href=\"https:\/\/www.massdevice.com\/boston-scientific-acquire-nalu-medical-533m\/\" title=\"\" target=\"_blank\" >Boston Scientific to acquire Nalu Medical for $533M<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-839\"><a href=\"https:\/\/www.beckershospitalreview.com\/supply-chain\/jj-to-spin-off-orthopedics-business\/\" title=\"\" target=\"_blank\" >J&J to spin off orthopedics business<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-834\"><a href=\"https:\/\/www.medicaldevice-network.com\/news\/medtech-europe-report-boosts-optimism-in-thriving-eu-medtech-sector\/?cf-view\" title=\"MedTech Europe highlighted that there were 15,700 medtech patent applications in 2024, doubling the rate of those in pharma and biotech.\r\nA new report by MedTech Europe indicates that Europe\u2019s medical technology sector is continuing to innovate and grow in economic strength.\r\nThe trade body\u2019s report revealed that Europe\u2019s overall medical technology market was worth around \u20ac170bn ($198.6bn) in 2024, with the sector employing over 930,000 staff.\r\n\r\nAccording to MedTech Europe, digital health is rapidly scaling in Europe as a result of the convergence between breakthrough technologies, patient empowerment, and systemic efficiencies.\r\n\r\nMedical technology applications with the European Patent Office (EPO) came in at 15,700 in 2024, corresponding to 7.9% of all EPOs.\" target=\"_blank\" >MedTech Europe report boosts optimism in \u2018thriving\u2019 EU medtech sector<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-831\"><a href=\"https:\/\/www.medicaldevice-network.com\/news\/terumo-agreement-buy-organox\/\" title=\"\" target=\"_blank\" >Terumo signs agreement to buy OrganOx for $1.5bn<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-828\"><a href=\"https:\/\/www.medicaldevice-network.com\/news\/alcon-strikes-1-bn-deal-to-acquire-ailing-rival-staar-surgical\/\" title=\"\" target=\"_blank\" >Alcon strikes $1.5bn deal to acquire rival STAAR Surgical<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-822\"><a href=\"https:\/\/www.mddionline.com\/ma\/measuring-medtech-s-m-a-appetite-in-2025\" title=\"Medtech has already seen a strong showing of M&amp;A activity this month, starting with Stryker announcing its intention to buy Inari Medical in a deal valued at $4.9 billion. Next came Boston Scientific pulling the trigger on Bolt Medical, a company it had invested in since 2019. We&#039;ve even seen some acquisition activity on the supplier side of medtech, including Geon Performance Solutions acquiring Foster, and Phillips Medisize buying Vectura Group.\r\nIs it too soon to get our hopes up for more to come on the medtech M&amp;A front in 2025? We&#039;ve combed through presentations from the J.P. Morgan Healthcare Conference that wrapped up last week, along with recent earnings reports, to find out which medtech companies are hungry for M&amp;A this year and which companies are likely to be a bit more picky with their capital allocations. [...]\r\nAbbott CEO: There&#039;s opportunities in med-tech, there&#039;s opportunities in diagnostics, and we&#039;re in a great position, and it allows us to be selective. [...]\r\nJ&amp;J CEO: Larger opportunities have to be seen more like outliers. [...]\r\nMedtronic CEO: We&#039;re on the hunt for tuck-in M&amp;A. [...]\r\nBoston Scientific CFO: The world is our oyster relative to M&amp;A. [...]\r\nGE HealthCare: Strong balance sheet allows for organic investment and opportunistic M&amp;A. [...]\" target=\"_blank\" >Measuring Medtech's M&A Appetite in 2025<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-820\"><a href=\"https:\/\/www.reuters.com\/markets\/deals\/starboard-value-pushes-becton-dickinson-sell-life-sciences-unit-ft-reports-2025-02-03\/\" title=\"\" target=\"_blank\" >Becton Dickinson looks to divest life sciences unit at $30 billion valuation, source says<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-818\"><a href=\"https:\/\/interventionalnews.com\/teleflex-announce-acquisition-of-biotroniks-vascular-intervention-business\/\" title=\"\" target=\"_blank\" >Teleflex announce acquisition of Biotronik\u2019s Vascular Intervention business<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-815\"><a href=\"https:\/\/www.aha.org\/aha-center-health-innovation-market-scan\/2025-03-04-3-ways-robotic-surgery-changing-health-care-year\" title=\"1 | Competition will heat up.\r\n\r\nAfter long enjoying an overwhelming market share, Intuitive is facing more competitors this year. Not only is the competition coming from well-established medtech companies like Stryker, Medtronic and J&amp;J, but also from new market entrants with specialty applications and modular concepts with smaller devices that are easier to move around. [...]\r\n\r\n2 | Look for expanded use of surgical robots in ambulatory surgery centers (ASCs).\r\n\r\nThere has been a rush to install orthopedic robots in ASCs, and that trend will continue this year as large-joint replacement continues to grow, Morningstar analyst Debbie Wang recently told MedTech Dive. Stryker and Zimmer Biomet are adding shoulder features to their surgical robots, the report notes. Spine surgery also has the potential to benefit from an expanding focus on robotics, according to Wang. [...]\r\n\r\n3 | AI will continue to play a larger role in surgical robots.\r\n\r\nStryker&#039;s Mako Shoulder robotic surgical assistant for shoulder replacement and Mako Spine for spine-replacement surgeries use an AI technology called Blueprint that helps surgeons better understand shoulder deformities and their patients\u2019 pathology to predict potential challenges and evaluate different implant options. [...]\" target=\"_blank\" >3 Ways Robotic Surgery Is Changing Health Care In 2025<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-813\"><a href=\"https:\/\/en.globes.co.il\/en\/article-boston-scientific-buys-israeli-medical-device-co-sonivie-1001503621\" title=\"\" target=\"_blank\" >Boston Scientific buys Israeli medical device co SoniVie<\/a><\/li><li class=\"simple-links-item simple-links-shortcode-item\" id=\"link-808\"><a href=\"https:\/\/www.reuters.com\/markets\/deals\/starboard-value-pushes-becton-dickinson-sell-life-sciences-unit-ft-reports-2025-02-03\/\" title=\"\" target=\"_blank\" >Becton Dickinson looks to divest life sciences unit at $30 billion valuation<\/a><\/li><\/ul><!-- End .simple-links-list -->\n<\/div><\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<div class=\"wp-block-cover alignfull is-light\" style=\"min-height:472px;aspect-ratio:unset;\"><span aria-hidden=\"true\" class=\"wp-block-cover__background has-nv-dark-bg-background-color has-background-dim-100 has-background-dim\"><\/span><div class=\"wp-block-cover__inner-container is-layout-flow wp-block-cover-is-layout-flow\">\n<div style=\"height:58px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center has-nv-text-dark-bg-color has-text-color\">Let\u2019s discuss about how we can work together on your next medtech project and <br>how I can add value to your business<\/h2>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\">Please contact us for a first discussion on your current projects, pipeline and portfolio.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-horizontal is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-7d812b4c wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-primary\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/medtechkey.com\/index.php\/contact\/\">LEARN MORE<\/a><\/div>\n<\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Latest Medtech News Top Stories Latest News<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/template-pagebuilder-full-width.php","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"left","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"off","neve_meta_disable_footer":"","neve_meta_disable_title":"on","footnotes":""},"class_list":["post-417","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/medtechkey.com\/index.php\/wp-json\/wp\/v2\/pages\/417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medtechkey.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/medtechkey.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/medtechkey.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medtechkey.com\/index.php\/wp-json\/wp\/v2\/comments?post=417"}],"version-history":[{"count":13,"href":"https:\/\/medtechkey.com\/index.php\/wp-json\/wp\/v2\/pages\/417\/revisions"}],"predecessor-version":[{"id":571,"href":"https:\/\/medtechkey.com\/index.php\/wp-json\/wp\/v2\/pages\/417\/revisions\/571"}],"wp:attachment":[{"href":"https:\/\/medtechkey.com\/index.php\/wp-json\/wp\/v2\/media?parent=417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}